Literature DB >> 32434940

Immune Complex-Driven Generation of Human Macrophages with Anti-Inflammatory and Growth-Promoting Activity.

Elizabeth Dalby1, Stephen M Christensen1, Jingya Wang2, Kajal Hamidzadeh1, Prabha Chandrasekaran1, V Keith Hughitt1,3, Wagner Luiz Tafuri4, Rosa Maria Esteves Arantes4, Ismael Alves Rodrigues5, Ronald Herbst2, Najib M El-Sayed1,3, Gary P Sims6, David M Mosser7.   

Abstract

To maintain homeostasis, macrophages must be capable of assuming either an inflammatory or an anti-inflammatory phenotype. To better understand the latter, we stimulated human macrophages in vitro with TLR ligands in the presence of high-density immune complexes (IC). This combination of stimuli resulted in a broad suppression of inflammatory mediators and an upregulation of molecules involved in tissue remodeling and angiogenesis. Transcriptomic analysis of TLR stimulation in the presence of IC predicted the downstream activation of AKT and the inhibition of GSK3. Consequently, we pretreated LPS-stimulated human macrophages with small molecule inhibitors of GSK3 to partially phenocopy the regulatory effects of stimulation in the presence of IC. The upregulation of DC-STAMP and matrix metalloproteases was observed on these cells and may represent potential biomarkers for this regulatory activation state. To demonstrate the presence of these anti-inflammatory, growth-promoting macrophages in a human infectious disease, biopsies from patients with leprosy (Hanseniasis) were analyzed. The lepromatous form of this disease is characterized by hypergammaglobulinemia and defective cell-mediated immunity. Lesions in lepromatous leprosy contained macrophages with a regulatory phenotype expressing higher levels of DC-STAMP and lower levels of IL-12, relative to macrophages in tuberculoid leprosy lesions. Therefore, we propose that increased signaling by FcγR cross-linking on TLR-stimulated macrophages can paradoxically promote the resolution of inflammation and initiate processes critical to tissue growth and repair. It can also contribute to infectious disease progression.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32434940      PMCID: PMC9358719          DOI: 10.4049/jimmunol.1901382

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  72 in total

1.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

3.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  In Vitro Analysis of the Expression of CD11, CD29, CD36, and DC-STAMP Molecules during the Formation of Multinuclear Macrophages in BCG-Infected Mice.

Authors:  D A Il'in; V A Shkurupy
Journal:  Bull Exp Biol Med       Date:  2019-10-22       Impact factor: 0.804

Review 5.  Th1-Th2 paradigm: insights from leprosy.

Authors:  R L Modlin
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551

6.  Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication.

Authors:  J K Damås; L Landrø; B Fevang; L Heggelund; G E Tjønnfjord; Y Fløisand; B Halvorsen; S S Frøland; P Aukrust
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

7.  TIRF imaging of Fc gamma receptor microclusters dynamics and signaling on macrophages during frustrated phagocytosis.

Authors:  Jia Lin; Svetlana Kurilova; Brandon L Scott; Elizabeth Bosworth; Bradley E Iverson; Elizabeth M Bailey; Adam D Hoppe
Journal:  BMC Immunol       Date:  2016-03-12       Impact factor: 3.615

8.  Transmembrane 7 superfamily member 4 regulates cell cycle progression in breast cancer cells.

Authors:  X X Zeng; T J Chu; J Y Yuan; W Zhang; Y M Du; Z Y Ban; D M Lei; J Cao; Z Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-11       Impact factor: 3.507

9.  PI3K-dependent GSK3ß(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response.

Authors:  Thomas Karrasch; Tanja Spaeth; Brigitte Allard; Christian Jobin
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

10.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

View more
  4 in total

1.  Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis.

Authors:  Gemma D Banham; Colin Y C Lee; John R Ferdinand; Rebeccah J Matthews; Chenzhi Jing; Nicholas Smithers; Rab K Prinjha; Menna R Clatworthy
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

Review 2.  Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation.

Authors:  Fabian Junker; John Gordon; Omar Qureshi
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

3.  Humoral immunity in leishmaniasis - Prevention or promotion of parasite growth?

Authors:  Ricardo Goncalves; Stephen M Christensen; David M Mosser
Journal:  Cytokine X       Date:  2020-10-31

4.  High-Density-Immune-Complex Regulatory Macrophages Promote Recovery of Experimental Colitis in Mice.

Authors:  Tamara Cristina Moreira Lopes; Gregório Guilherme Almeida; Izabela Aparecida Souza; Diego Costa Borges; Wanderson Geraldo de Lima; Pedro Henrique Dias Moura Prazeres; Alexander Birbrair; Rosa Maria Esteves Arantes; David M Mosser; Ricardo Goncalves
Journal:  Inflammation       Date:  2021-01-04       Impact factor: 4.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.